Cargando…
Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer
A-to-I RNA editing can contribute to the transcriptomic and proteomic diversity of many diseases including cancer. It has been reported that peptides generated from RNA editing could be naturally presented by human leukocyte antigen (HLA) molecules and elicit CD8+ T cell activation. However, a syste...
Autores principales: | Zhou, Chi, Wei, Zhiting, Zhang, Liye, Yang, Zhaoyi, Liu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758481/ https://www.ncbi.nlm.nih.gov/pubmed/33363023 http://dx.doi.org/10.3389/fonc.2020.593989 |
Ejemplares similares
-
The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis
por: Wei, Zhiting, et al.
Publicado: (2019) -
ASNEO: Identification of personalized alternative splicing based neoantigens with RNA-seq
por: Zhang, Zhanbing, et al.
Publicado: (2020) -
The Role of Neoantigens in Cancer Immunotherapy
por: Zhu, Yueting, et al.
Publicado: (2021) -
The Clinical Application of Neoantigens in Esophageal Cancer
por: Gu, Yi-Min, et al.
Publicado: (2021) -
A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects
por: Wang, Heming, et al.
Publicado: (2021)